全文获取类型
收费全文 | 10855篇 |
免费 | 819篇 |
国内免费 | 291篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 113篇 |
妇产科学 | 158篇 |
基础医学 | 1512篇 |
口腔科学 | 485篇 |
临床医学 | 1135篇 |
内科学 | 1014篇 |
皮肤病学 | 91篇 |
神经病学 | 600篇 |
特种医学 | 938篇 |
外国民族医学 | 3篇 |
外科学 | 1106篇 |
综合类 | 1507篇 |
现状与发展 | 1篇 |
预防医学 | 693篇 |
眼科学 | 70篇 |
药学 | 580篇 |
6篇 | |
中国医学 | 479篇 |
肿瘤学 | 1396篇 |
出版年
2024年 | 44篇 |
2023年 | 207篇 |
2022年 | 392篇 |
2021年 | 464篇 |
2020年 | 428篇 |
2019年 | 360篇 |
2018年 | 330篇 |
2017年 | 350篇 |
2016年 | 404篇 |
2015年 | 421篇 |
2014年 | 670篇 |
2013年 | 681篇 |
2012年 | 630篇 |
2011年 | 689篇 |
2010年 | 539篇 |
2009年 | 592篇 |
2008年 | 523篇 |
2007年 | 551篇 |
2006年 | 504篇 |
2005年 | 456篇 |
2004年 | 382篇 |
2003年 | 305篇 |
2002年 | 238篇 |
2001年 | 203篇 |
2000年 | 175篇 |
1999年 | 150篇 |
1998年 | 137篇 |
1997年 | 105篇 |
1996年 | 110篇 |
1995年 | 106篇 |
1994年 | 97篇 |
1993年 | 65篇 |
1992年 | 89篇 |
1991年 | 75篇 |
1990年 | 55篇 |
1989年 | 42篇 |
1988年 | 47篇 |
1987年 | 47篇 |
1986年 | 33篇 |
1985年 | 51篇 |
1984年 | 41篇 |
1983年 | 35篇 |
1982年 | 31篇 |
1981年 | 22篇 |
1980年 | 15篇 |
1979年 | 18篇 |
1978年 | 12篇 |
1977年 | 13篇 |
1976年 | 9篇 |
1973年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
3.
Taisuke Inada Satoshi Fukushima Masayuki Murai Masatoshi Jinnin Azusa Miyashita Satoshi Nakahara Junji Yamashita Jun Aoi Shinichi Masuguchi Hironobu Ihn 《The Journal of dermatology》2015,42(2):198-201
miRNA‐221 (miR‐221) is known to be abnormally expressed in many human cancers. The serum levels of miR‐221 have been reported as a tumor marker for malignant melanoma (MM). We hypothesized that the hair shaft miR‐221 levels may be increased in patients with MM. We therefore assessed the possibility that hair shaft miR‐221 levels could be a marker for MM. The hair shaft miR‐221 levels were significantly higher in patients with MM than controls. The rates of increased hair shaft miR‐221 levels above the cut‐off value were comparable to those of serum 5‐S‐CD, which is a tumor marker commonly used for MM. Measurements of the hair shaft miR‐221 levels could have potential clinical value in the detection of MM. This is the first report investigating the hair shaft levels of an miRNA in patients with MM. Our investigations offer new insight into the relationship between miR‐221 and MM, and may provide a new, non‐invasive way to screen for melanoma. 相似文献
4.
《Clinical Lymphoma, Myeloma & Leukemia》2020,20(8):e461-e467
IntroductionVon Willebrand factor (vWF) cleaving protease ADAMTS-13 has a key role for maintaining normal size of vWF. A deficiency or dysfunction of vWF cleaving protease is associated with ultra large vWF multimers and thrombotic microangiopathy. Patients with cancers have reduced levels of vWF cleaving protease. In this pilot study, we have evaluated whether or not deficiencies of ADAMTS-13 were present in myelodysplastic syndromes (MDS). Moreover, we assessed if a reduction in basal levels of ADAMTS-13 may play a role in the prognosis of MDS.Patients and MethodsWe measured and compared the levels of vWF cleaving protease ADAMTS-13 in 100 patients with MDS and 35 healthy controls. Patients were divided into 2 groups according to the International Prognostic Scoring System: group I consisting of 44 patients with low-risk MDS and group II of 56 patients with high-risk MDS. Patients with high-risk and low-risk MDS presented significantly lower levels of ADAMTS-13 than controls (P < .001 and P = .0177, respectively). High-risk patients had significantly lower levels of ADAMTS-13 when compared with the low-risk group (P < .001).ResultsWe found that reduced levels of ADAMTS-13 have a relationship with overall survival (P < .001). Statistical analysis showed that ADAMTS-13 correlates with cytogenetics (P < .001) and a tendency of slight correlation with platelet count and basal levels of ADAMTS-13 (R, 0.35; P value, 0.001). Moreover, we found that levels of ADAMTS-13 have correlation with response to treatment (P < .001).ConclusionsADAMTS-13 in MDS might represent a surrogate marker of prognosis, response to therapy, or disease progression. Further studies are needed. 相似文献
5.
6.
Background Context
Long-term follow-up of patient-reported outcome measures (PROM) is essential in both modern spinal care and research. Lack of time and staff are commonly reported barriers to implementing long-term follow-up of PROM. Automated and digital follow-up systems for PROM collection are seeing widespread use, yet their validity and comparative effectiveness have never been evaluated.Purpose
The present study aimed to assess the validity of digital follow-up systems in comparison with the conventional paper-based follow-up (PB-FU).Study Design
This is a retrospective analysis of prospectively collected double follow-up data.Patient Sample
Patients who underwent lumbar spinal fusion for spondylolisthesis or degenerative disc disease between 2013 and 2016 were included in the study.Outcome Measures
The study determined the Oswestry Disability Index (ODI) and Numeric Rating Scale (NRS) for back and leg pain severity at baseline, 6 weeks, 12 months, and 24 months.Materials and Methods
After lumbar spinal fusion surgery, a double follow-up of PROM was carried out by conventional PB-FU during clinical visits, while simultaneously completing an automatically dispatched digital follow-up questionnaire. As the primary end point, we assessed the intraindividual discrepancy in PROM between PB-FU and automated digital follow-up (AD-FU).Results
Forty patients completed all parts of the dual follow-up trajectory and were analyzed. We detected no discrepancy in ODI or NRS for back and leg pain severity at any of the baseline, 6-week, 12-month, or 24 month follow-ups (all p>.05). This was confirmed in a sensitivity analysis.Conclusions
In an analysis of dual paper-based and digital follow-up after lumbar fusion surgery, patients report highly similar values using either method of follow-up. It appears that AD-FU without incentives produces lower response rates. To reassess the validity of these systems for data collection in spinal patient care, a prospective validation with higher statistical power is warranted. 相似文献7.
目的应用6σ理论对肿瘤标志物项目的分析性能进行评价,并初步确定各项目的质量目标。
方法收集本实验室2018年1至12月室内质控数据和国家卫生健康委临床检验中心室间质量评价结果,以生物学变异导出的质量规范和国家室间质量评价标准作为允许总误差(TEa)计算6项肿瘤标志物的σ水平,并依据质量目标选择流程图和肿瘤标志物分析性能验证图评价肿瘤标志物的分析性能,进而为肿瘤标志物选择合适的质量目标。
结果应用不同层级的生物学变异导出的质量规范和国家室间质量评价标准,肿瘤标志物项目的σ水平存在显著差异;依据质量目标选择流程图:选择生物学变异导出的"适当的"质量规范作为CA125项目的质量目标,选择生物学变异导出的"最低的"质量规范作为t-PSA、CEA、AFP、CA199和CA153项目的质量目标。
结论6σ能够客观评价肿瘤标志物的分析性能,并为实验室质量目标的选择提供重要的参考价值。 相似文献
8.
《ALTER. European Journal of Disability research, Journal europeen de recherche sur le handicap》2020,14(2):71-84
This article examines self-representations in a social media campaign against the discrimination of people with disabilities. We focus specifically on how these representations are related to various narratives and discourses, and in what ways the representations either adhere to or challenge normative discourses, or whether they offer counter-discourses. Considering that our cultural assumptions are influenced by the representations we are exposed to, we also discuss the possible potential of self-representations for the audience of the campaign. The empirical material consists of a digital activism campaign conducted on Instagram in Sweden that was constructed through self-representations (photos and short texts). The study combines discourse analysis and visual analysis with focus on how the persons present themselves in the campaign, how disability is mentioned and/or displayed, and how a presentation adheres to or challenges a model of understanding disability, such as the medical or social models. We found a diverse set of claims, all with the common goal of acknowledging discrimination, in order to make it visible and bring about change. The narratives identified indicate a variety of strategies for understanding disability and various styles that people adopt to relate to established discourses on disabilities. Through this campaign, the bloggers could find and provide support, but they also took the stage by requesting that the audience listen. The campaign examined in this study can be further understood as an effort and a step towards increased visibility and politicization of disability. 相似文献
9.
10.
目的 评价缺血修饰性白蛋白(ischemia modified albumin,IMA)对急性缺血性胸痛(ICP)的早期诊断价值。方法 时206例发病〈12h、表现为急性胸痛的患者立即行12导联心电图(ECG)检查,并抽血进行IMA、肌钙蛋白I(cTnI)、肌酸激酶同工酶MB(CK-MB)测定。将ECG、IMA、cTnI、CK-MB的结果单独或结合与最终诊断为非缺血性胸痛(NICP)及ICP的相互关系进行比较。结果 最后诊断为ICP98例,NICP108例,ICP发病〈3h和3-6h组IMA水平明显升高,与NICP组比较差异有统计学意义(P〈0.001);ICP发病〉6h组IMA水平与NICP组比较差异无统计学意义(P〉0.05)。IMA诊断发病〈3hICP的敏感性和阴性预测值(NPV)为89.1%和88.8%,明显高于ECG、cTnI和CK-MB,四者结合为97.6%和96.9%;IMA诊断发病3~6hICP的敏感性和NPV为71.7%和74.5%,也高于ECG、cTnI、CK-MB,四者结合为95.5%和94.2%;但IMA对于发病〉6h的ICP则无诊断作用。结论 IMA是诊断ICP的早期敏感生化指标,对于发病〈6h(尤其是〈3h)的ICP诊断具有较高的敏感性和NPV,优于ECG、CK-MB、cTnI;将IMA与其他指标结合,可进一步提高对ICP的诊断价值。 相似文献